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ABSTRACT 
Aspergillosis is a fungal infection caused by Aspergillus molds that can affect both humans and 
animals. Despite advances in diagnostics and therapy, medical management of this disease 
remains difficult. Expansion of the basic knowledge regarding its pathophysiology in animals is 
critical to aid in the identification of new biomarkers of infection for diagnosis and therapeutic 
targets. For such a purpose, proteomics can be used by addressing protein changes during various 
disease processes. In the present study, a mass spectrometry analysis based on isobaric tagging 
for relative and absolute quantitation (iTRAQ
®
) was applied for direct identification and relative 
quantitation of proteins in blood collected from 32 Aspergillus-diseased common bottlenose 
dolphins (Tursiops truncatus, 32 samples) in comparison with blood from 55 other dolphins (55 
samples from 41 clinically-normal controls and from 14 cetaceans with miscellaneous non-
Aspergillus inflammation diseases) and ten convalescent dolphins (28 samples). Sixty-six and 40 
proteins were found to be ≥2.0-fold over- and underrepresented versus miscellaneous non-
Aspergillus inflammatory dolphins, respectively, and most were confirmed vs. clinically-normal 
controls and convalescents. Many proteins which play a role in the adaptive immune response 
were identified, including MHC proteins and others involved in catalytic activity like the 
NADPH-ubiquinone oxido-reductases. Overall, iTRAQ
®
 appears to be a convenient proteomic 
tool greatly suited for exploratory ex vivo studies focusing on pathophysiology. This technique 
should be considered as a preliminary step before validation of new diagnostic markers.  
 
KEY WORDS: Aspergillosis; Dolphin; Interleukin; Orbitrap; Prepronociceptin; Protamine P1; 
Tursiops truncatus  
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INTRODUCTION 
Aspergillosis is an airborne fungal infection caused by saprophytic ubiquitous molds that belong 
to the Aspergillus genus (Latgé, 1999). It is responsible for several distinct respiratory diseases in 
both humans and animals. In marine mammals, Aspergillus-related disease is assumed to be rare, 
but it has been reported with increasing incidence: 66.7% of the 18 reported cases have been 
published after the year 2000 (Dagleish et al., 2008; Abdo et al., 2012). Aspergillosis can involve 
the lungs and brain in cetaceans (Latgé, 1999; Seyedmousavi et al., 2015). The major species 
responsible for infection belong to the Fumigati section (Lamoth, 2016), Nigri section and Terrei 
section in which A. fumigatus stricto sensu (ss), A. niger ss and A. terreus ss are the most 
frequently isolated (Balajee, 2009), respectively. 
In marine mammals, and especially in dolphins, diagnostic tools are less developed than those 
for humans (Dagleish et al., 2008; Cassle et al., 2016). For instance, quantitative polymerase 
chain reaction (qPCR) has not been widely implemented in veterinary laboratories, and advanced 
medical imaging (computed tomography (CT), magnetic resonance imaging (MRI)) may not be 
accessible. Moreover, a positive culture from respiratory specimens does not definitively 
diagnose a true infection as it may reflect a simple colonization of the upper airways or represent 
an environmental contaminant (Desoubeaux et al., 2014). Also, as reported in humans, the 
sensitivity of blood cultures is very low for Aspergillus spp (Desoubeaux et al., 2014). 
Furthermore, detection of galactomannan antigen (GM) was demonstrated to be unreliable 
(Desoubeaux et al., 2017a). Conversely, serologic testing by western blot has been demonstrated 
to accurately detect anti-Aspergillus antibody in dolphin blood (Desoubeaux et al., 2017a). Thus, 
additional and novel biomarkers for aspergillosis should be investigated to improve the basic 
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understanding of the pathophysiology of this disease. Evaluation of biomarkers in the host 
response may be able to provide such information. 
Within the last decade, proteomics has been largely used for addressing significant protein 
changes within diseased organisms or pathologic fluids (Fekkar et al., 2012; Desoubeaux et al., 
2013). Innovative mass spectrometry (MS) tools were initially developed for identification and 
qualitative characterization; however, some are now able to directly quantitate the relative 
amount of proteins identified. For instance, iTRAQ® (isobaric tags for relative and absolute 
quantitation) is an isobaric labeling method to identify and to determine the amount of proteins 
from different multiplexed sources within a single-run experiment (Ross et al., 2004; 
Desoubeaux et al., 2017b). This technique uses stable isotope-tagged molecules that can be 
covalently bonded to the N-terminus and side chain amines of trypsin-digested peptides 
(Bourassa et al., 2015; Desoubeaux et al., 2018). In the present study, through an original MS 
approach based on iTRAQ®, we attempted to bring new insight to the host protein response 
against Aspergillus in diseased common bottlenose dolphins (Tursiops truncatus).  
 
MATERIAL AND METHODS 
Animals 
Study population: inclusion and samples 
Over 15 years, 115 blood samples were opportunistically collected during routine or clinical 
health assessments from 87 common bottlenose dolphins (Tursiops truncatus) under human care 
(from 2002 to 2016 (except for four samples obtained in 1991, 1993, 1993, and 1995), but 62.8% 
obtained over the last three years). The cetaceans were hosted in several different facilities 
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throughout the United States of America (U.S.A.). All blood samples were centrifuged and 
plasma specimens were stored at -20C or -80°C prior to being utilized for MS.  
No dolphins were anesthetized or euthanized for the purposes of this study. This study was 
conducted using archived samples collected from Six Flags Aquarium, Georgia Aquarium, 
Chicago Zoological Society (CZS), and US Navy marine mammals as part of their routine care. 
The US Navy Marine Mammal Program (MMP) houses and cares for a population of dolphins in 
San Diego Bay (CA, USA). The MMP is Association for Assessment and Accreditation of 
Laboratory Animal Care (AAALAC)-accredited and adheres to the national standards of the 
United States Public Health Service on the Human Care and Use of Laboratory Animals and the 
Animal Welfare Act. Georgia Aquarium and CZS are USDA/APHIS approved and inspected 
facilities and members of the Association of Zoos and Aquariums and the Alliance of Marine 
Mammal Parks and Aquariums. Both have been awarded the Humane Conservation certification 
by American Humane. Biological samples for this study were taken as a part of a preventative 
medicine program or for medical monitoring purposes. 
 
Case definitions 
Aspergillosis classification in dolphins was derived from the definition utilized in human 
medicine (De Pauw et al., 2008; Arendrup et al., 2012; Marchetti et al., 2012). For example, the 
definitive diagnosis of “proven” aspergillosis was based upon histopathologic evidence 
(Desoubeaux et al., 2014). The diagnosis of “probable” aspergillosis was based upon positive 
mycological culture in conjunction with clinical examination, imaging investigations, and any 
clinical signs which could corroborate the diagnosis. Since GM detection was shown to be 
unreliable in cetaceans, it was not considered to be a pivotal parameter for the diagnosis of 
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“probable” infection (Desoubeaux et al., 2017a). Notably, samples obtained from dolphins with 
clinical signs consistent with possible aspergillosis, but with no positive mycological cultures, 
were excluded from the subsequent analysis, unless they had significant anti-Aspergillus 
antibody titers, i.e. equal or superior to 1: 512 ELISA titers (Desoubeaux et al., 2017a). 
Altogether, 32 dolphins (n1) were included in the Aspergillus-diseased group. An additional 
category, referred to as convalescent, was defined for that recovered from aspergillosis, i.e. 
sampling date greater than three months after the diagnosis, if clinical improvement was noticed 
and/or long-term antifungal therapy was given. Thus, twenty-eight samples were obtained from 
ten of the n1 aforementioned cetaceans. In average, convalescent dolphins were tested 2.8 ± 1.6 
times, 47.7 ± 40.8 months after the initial diagnosis of aspergillosis. 
Animals with no apparent clinical signs were considered as healthy controls and classified into 
the clinically-normal group (n2’=41), while those undergoing miscellaneous non-Aspergillus 
inflammatory processes were classified as non-Aspergillus inflammatory dolphins (n2’’= 14).  
 
Proteomic analysis 
Pre-processing step with iTRAQ
®
-tags labeling 
This protocol was the same as described previously (Desoubeaux et al., 2018). Briefly, protein 
enrichment was completed using the Pierce Albumin / IgG removal
®
 kit (ThermoFisher 
Scientific, Waltham, MA, U.S.A.) that allows for depletion of overrepresented proteins like 
albumin or immunoglobulins (Kumar et al., 2012). Total protein content was quantified by the 
Pierce BCA Protein assay
®
 kit (ThermoFisher Scientific, Waltham, MA, U.S.A.), according to 
the manufacturer’s instructions (Kumar et al., 2012; Desoubeaux et al., 2013). All depleted blood 
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samples were thereafter pooled, on the basis of 1,000 µg protein for each, in four distinct 
aliquots, according to the clinical group the dolphins were affiliated with: clinically-normal 
controls, non-Aspergillus inflammatory dolphins, Aspergillus-diseased animals, and convalescent 
subjects. Then, 100 g of every pool was incubated with 30 L dissolution buffer of 0.5 M 
triethylammonium bicarbonate (Sigma-Aldrich, Saint-Louis, MO, U.S.A.) at pH 8.5, and 
thereafter treated with 2.0% SDS-denaturant solution. One microliter of tris-(2-
carboxyethyl)phosphine-reducing reagent was added, followed by vortex-shaking for 1 min, 
centrifugation at 18,000 x g for 5 min and incubation at 60C for 1 h. After another step of 
shaking and centrifugation, 84 mM iodoacetamide was added for a 30 min-long incubation in the 
dark at room temperature. Freshly prepared 0.1 g/L sequencing grade modified trypsin was 
then mixed with each sample, and digestion was carried out at 37C during 30 min. Thereafter, 
1 L trypsin was added to continue digestion overnight. The samples were dried in an Eppendorf 
Vacufuge
®
 concentrator, and then reconstituted with 30 L dissolution buffer. Every tube was 
mixed with one unique iTRAQ
®
 reagent (Sigma-Aldrich, Saint-Louis, MO, U.S.A.) and 
reconstituted in isopropanol, according to the manufacturer’s recommendations. The tube 
containing all the blood samples pooled from clinically-normal controls was mixed with the 117-
reagent, those from miscellaneous non-Aspergillus inflammatory dolphins with the 118-reagent, 
those from Aspergillus-diseased dolphins with the 119-reagent, and those from Aspergillus-
convalescent dolphins with the 121-reagent. Thereafter, the contents of all these iTRAQ
®
 
reagents-labelled tubes were combined into one single tube, vortexed for 1 min, and centrifuged 
at 18,000 g for 5 min. The multiplexed specimen was thoroughly dried by centrifugal vacuum 
concentration as above.  
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Processing steps by mass spectrometry 
The multiplexed iTRAQ
®
 specimen was re-suspended in 2.0% acetonitrile and loaded onto a 
high performance liquid chromatographic (HPLC) instrument. HPLC analysis was conducted in 
an Easy Nano LC 1000
®
 model (ThermoFisher Scientific, Waltham, MA, U.S.A.) where a 
75 µm i.d. x 15 cm column, packed with Acclaim PepMap
®
 RSLC C18-2 µm 100 Å column 
(ThermoFisher Scientific, Waltham, MA, U.S.A.), was in-line connected to a Acclaim PepMap
®
 
100 75 um x 2 cm, nanoviper C18-3 µm 100 Å pre-column (ThermoFisher Scientific, Waltham, 
MA, U.S.A.). Peptides were eluted following a 75 min gradient from 2.0 % to 98.0 % 
acetonitrile (ThermoFisher Scientific, Waltham, MA, U.S.A.) with a water flow of 350 nL/min 
into a QExactive
®
 Orbitrap mass spectrometer (ThermoFisher Scientific, Pittsburg, PA, U.S.A.) 
in data-dependent mode, with an automatic gain control (AFC) target of 1.0x10
6
 for full MS at 
70,000 resolution, and of 2.0x10
5
 for dd-MS
2 
at 17,500 resolution in positive mode. The isolation 
window was fixed to 1.5 m/z with normalized collision energy of 28 eV, underfill ratio of 1.0%, 
and dynamic exclusion of 3.0. First mass was fixed to 103 m/z. QExactive
®
 Orbitrap typical 
technical specifications are evaluated as follows: high resolving power of 140,000 full width at 
half maximum, defined at m/z 200, and elevated resolution at Δm/z=0.001, with a 50-4,000 m/z 
range (Holčapek et al., 2012). 
 
Mass spectrometry data analysis and identification/quantitation of host proteins 
The bioinformatics analysis was performed using Proteome Discoverer
®
 software (ThermoFisher 
Scientific, Pittsburg, PA, U.S.A.). Specific SwissProt
®
 reviewed non-redundant databases 
(http://www.uniprot.org/uniprot/) were used for the analysis of dolphin or dolphin-like 
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(according to the following genera: Tursiops, Cephalorhynchus, Grampus, Lagenorhynchus, 
Platanista, Sotalia, Stenella, Inia, Lipotes, and Sousa) proteome using Sequest
®
 HT search 
engine (Washington DC, U.S.A.). The parameters of the study set trypsin as the enzyme used for 
digestion, with a maximum number of missed cleavage sites of two, 10 ppm as precursor mass 
tolerance, and 0.02 Da for fragment mass tolerance. Alkylation, as well as N-terminal / lysine 
modifications and dynamic iTRAQ
®
 modifications were selected as fixed. Maximum value for 
delta correlation was set to 0.05. False discovery rate target value was 0.01 for strict rate and 
0.05 for relaxed one, considering the q-value as a validation reference. At the quantification 
level, the analysis included Κ-means clustering, i.e. supervised and heuristic algorithm, for both 
protein and peptide quantitation ratios. The software actually worked by grouping proteins, based 
on the peptide spectral match (PSMs). Then, a customized ratio was calculated for every protein 
group as the median of all PSMs included in the protein group.  
 
Statistical analysis 
Statistical analyses were performed using XLStat
®
 v.2016.6.04 software (Addinsoft, Paris, 
France). Missing data, e.g. when the total volume of sample was insufficient to complete all the 
analyses, were managed by the method of mean imputation. The -risk was adjusted at 0.05. 
Regarding specifically the iTRAQ® data, we based inference on one-way analysis of variance 
(ANOVA) models, with the data analysis conducted one protein at a time (Unwin et al., 2005; 
Keshamouni et al., 2006), combining both normalization, i.e. bias removal, and assessment of 
differential protein expression in a single model fit to the collection of reporter ion peak areas, 
i.e. corrected for isotopic overlap, from all observed tandem mass spectra. Significant cutoff for 
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determination of over- or underrepresentation was set at ≥ 2-fold in comparison of the 
Aspergillus-diseased cases with the other three groups (Desoubeaux et al., 2018). Principal 
component analysis (PCA) was used to facilitate interpretation of the multivariate proteome 
dynamics dataset (Rao and Li, 2009). Data were z-scored prior to model building. 
 
 
RESULTS 
Study population and samples 
Characteristics of included dolphins are detailed in Table 1. Measurement of GM antigen in 
blood was not diagnostic, displaying the following mean values: 0.2 ± 0.1 versus 0.2 ± 0.2 
ng/mL for Aspergillus-diseased cases and controls. There was a significant difference between 
anti-Aspergillus antibody titers in diseased and control dolphins (p < 0.0001).  
 
Proteomic analysis 
Overall, MS analysis achieved identification of 1,385 proteins in dolphin blood. Sixty-six 
proteins were statistically overexpressed in Aspergillus-diseased dolphins vs. miscellaneous non-
Aspergillus inflammatory dolphins (Figure 1), i.e. 2.0% of the whole dolphin (Tursiops 
truncatus) proteome, and 52 / 66 (78.8%) were also overrepresented as compared to clinically-
normal dolphins. Out of the 66 proteins overrepresented, 48 / 66 (72.7%) were also in 
overabundance vs. clinically-normal controls, and 46.15% were located at the cell membrane and 
19.2% in the extracellular compartment. Fifty percent represented binding activity, whereas 
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35.7% and 25.0% were involved in catalytic processes and signal transduction (Figure 1). 
Thirteen (13 / 66; 19.7%) were dramatically increased ( 4.0-fold) when compared to 
miscellaneous non-Aspergillus inflammatory dolphins (Table 2), primarily potassium inwardly-
rectifying channel J1-like protein. There was a major presence of proteins belonging to the major 
histocompatibility complex (MHC): major histocompatibility complex class II beta chain and 
MHC class I antigen, increased by >100.00-fold and 4.48-fold. Similarly, some nicotinamide 
adenine dinucleotide phosphate- (NADPH-) ubiquinone oxido-reductases were also increased 
with Aspergillus infection. Except for NADH-ubiquinone oxidoreductase chain 5 and endothelin-
1 receptor, all of these 13 markedly-increased proteins returned to normal levels during the 
convalescent period.  
Forty proteins were underrepresented in Aspergillus-diseased dolphins vs. miscellaneous non-
Aspergillus inflammatory dolphins (Figure 1), which represents 1.1% of the dolphin proteome, 
and 31 / 40 (77.5%) were confirmed to be lower when compared to clinically-normal controls. 
Among these 40 proteins, 47.4% were located at the membrane cell, and 31.6% in the 
mitochondrion. Fifty-six percent, 36.0% and 28.0% expressed catalytic, binding and transport 
activities, respectively (Figure 1). Six proteins / 40 (15.0%) were reduced by ≥ 4.0-fold in 
Aspergillus-diseased dolphins vs. miscellaneous non-Aspergillus inflammatory dolphins: 
retinoblastoma binding protein 8, prepronociceptin, extra-spindle poles-like protein 1, NADH 
dehydrogenase subunit 2, interleukin 4 (IL-4), and NADH-ubiquinone oxidoreductase chain 2. 
The last four were also decreased in convalescent dolphins. 
 
DISCUSSION 
12 
 
 
 
 
In marine mammals, development of aspergillosis varies fundamentally in comparison to the 
infection in humans. For instance, in dolphins, it appears to be associated with a chronic invasive 
process; generally suggestive of another disease and/or (sub-)acute physiologic stress 
(Desoubeaux et al., 2017a) rather than associated with severe immunosuppression and profound 
neutropenia as observed in humans (Seyedmousavi et al., 2015). Underlying pulmonary disease 
may affect host defense mechanisms, leading to long-term colonization in dolphin lungs and 
potential invasion of bronchial tissue by Aspergillus spp (Reidarson et al., 1998). Other organs, 
including the brain, may also be infected following systemic dissemination (Dagleish et al., 
2008; Abdo et al., 2012). Thus, as observed in this study, the diagnosis of aspergillosis is 
particularly challenging in dolphins (Seyedmousavi et al., 2015; Desoubeaux et al., 2017a). For 
example, GM antigen is not contributive and true positive mycological cultures are infrequent; 
there is a common observation of colonization or chronic infection compared to humans. 
Therefore, it is critical to describe new biomarkers of aspergillosis to aid diagnosis and 
prognosis, to suggest alternative therapeutic targets, and to decrease the related morbidity and 
mortality in dolphins. 
Through its sensitivity and by comprehensively addressing the pathophysiology, proteomics may 
contribute to the discovery of new markers and their clinical validation in diseased animals 
(Desoubeaux et al., 2013). In such a context, iTRAQ
®
 appears to be an accurate and innovative 
technique based on an affordable ready-to-use kit (Kumar et al., 2012; Bourassa et al., 2015; 
Desoubeaux et al., 2017b, 2018), provided there is availability of a performant MS instrument. 
For this reason, we had to circumvent several technical limitations. First, we included relevant 
controls for reliable comparison: we rigorously enforced recruitment of samples from dolphins 
which experienced various inflammatory diseases, including other fungal infections like 
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mucormycosis and histoplasmosis. Second, to reduce disease misclassification, we used a 
composite criterion based on clinical data, histopathology, and mycological culture as it is 
consensually approved for disease classification in human infections (Desoubeaux et al., 2014). 
Lastly, given the probability of homologous proteins, we decided to consult broad SwissProt® 
databases. The latter voluntarily encompassed ten dolphin and dolphin-like genera in order to 
allow identification of more proteins when compared to browsing the database restricted to 
Tursiops truncatus species. Unfortunately, it was not possible to analyze protein enrichment 
according to the Gene Ontogeny (GO) (http://www.geneontology.org/) (Desoubeaux et al., 
2018), because all the current classification system, including PANTHER classification systems 
version 13.1 (released 2018-02-03) (Mi et al., 2017), are lacking data related to cetaceans. This 
highlights the critical need to increase current databases that poorly represent marginal micro- or 
macro-organisms.  
Our MS study described significant qualitative and quantitative changes in the dolphin blood 
proteome. This protein spectrum brought new insight into the host defense mechanisms and 
showed major involvement of proteins with binding and catalytic functions as previously 
observed with rats and penguins (Desoubeaux et al., 2018). A major moiety was expressed in the 
extracellular compartment or at the cell membrane which suggests that these proteins are 
massively discarded into circulation during Aspergillus infection. The major representation of 
proteins related to MHC underscores the role of adaptive immunity during aspergillosis in 
dolphins (Beineke et al., 2010). This also reemphasizes how anti-infectious responses vary based 
on the host: for instance in humans, adaptive immunity plays a minor role against Aspergillus 
infection, while polymorphonuclear neutrophils and macrophages are primarily recruited 
14 
 
 
 
 
(Dagenais and Keller, 2009). We made similar observations in a neutropenic rat model 
(Chandenier et al., 2009; Desoubeaux et al., 2018).  
Several NADPH-ubiquinone oxido-reductase proteins and cytochrome b were described as 
overrepresented in the current study. They are believed to be required for catalysis which 
functions in the transfer of electrons to the respiratory chain required for enzymatic activity to 
fight against aspergillosis. IL-4 was found largely decreased in our study. In other studies, IL-4-
deficient mice developed attenuated airway inflammation compared with wild-type rodents 
(Choi and Reiser, 1998), and we also observed increased protein expression related to the 
interleukin signaling pathway in our acute rat model of aspergillosis (Desoubeaux et al., 2018). 
Similarly, prepronociceptin concentration was moderately lower in Aspergillus-diseased 
dolphins vs. non-Aspergillus inflammatory animals, which is consistent with previous findings 
showing significant increase in systemic chronic inflammation models (Liu et al., 2012). In the 
dolphin, decreased prepronociceptin concentration can be hypothesized as a physiological 
adaptation to chronic infection caused by Aspergillus. As up-regulation of the prepronociceptin 
system was previously demonstrated to alter airway hyper-responsiveness (Singh et al., 2013), 
down-regulation can be assumed to play an opposite role in modulating airway inflammation and 
airway tone. Interestingly, bacterial infections were demonstrated to have significant negative 
impact on protamine P1 concentration (Zeyad et al., 2018) whereas Aspergillus-infection 
appeared to induce positive effects in dolphins, by increasing it more than 15-fold. This finding 
may suggest a potential clue for differential diagnosis between bacterial and fungal infections. 
Other studies have shown significant antimicrobial activity of protamine (Kim et al., 2015). 
Overall, the present study highlighted the potential of MS analysis for characterizing the 
pathophysiology of aspergillosis. Use of the iTRAQ
®
 protocol provided new insight on the host 
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inflammatory response against Aspergillus in naturally-infected mammals. This study may serve 
as a reliable preliminary trial towards the discovery of new biomarkers of infection and the 
suggestion of therapeutic targets. Further studies are warranted to validate these results and 
expand upon the construction of functional protein networks in aspergillosis. The example of 
iTRAQ
®
 protocol application for aspergillosis in dolphins should be easily reproducible for other 
diseases and in various host species.  
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FIGURE LEGEND 
Figure 1: Global protein changes in Aspergillus-diseased common bottlenose dolphins 
(Tursiops truncatus) versus non-Aspergillus inflammatory animals. In the upper panel, the bar 
graph indicates the absolute number of proteins that were found positively or negatively  2.0-
fold differentially-expressed. The extreme upper and lower parts of the bars (no hatching) 
represent the protein moiety  4.0-fold differentially-expressed. In the middle panel, the pie 
charts display the distribution of the subcellular locations for each differentially-expressed 
protein. In the lower panel, the bar graph shows the molecular functions of these proteins. 
